Trump Administration Trade Barriers Implications for MedTech in Asia

The Trump administration’s upcoming tariffs are set to have significant implications for the MedTech industry in APAC. Next Friday, 28 February, at 11 AM SGT, APACMed’s Government Affairs and Policy Committee will host a webinar as part of the Policy Intelligence Series 2025, offering key insights into these critical developments.

Join us as we explore:

• The impact of new tariffs and trade barriers on APAC markets

• Implications of regulatory shifts such as the pause in FCPA (Foreign Corrupt Practices Act) enforcement

• Strategies for MedTech leaders to navigate these evolving challenges

Featuring expert insights from:

• Alex Capri – Author of Techno-Nationalism & Senior Lecturer, NUS Business School

• Neena Shenai – Partner, WilmerHale

Don’t miss this opportunity to stay ahead of policy changes affecting MedTech in APAC.

Exclusively for APACMed Members. For enquiries, please contact [email protected].